Michael’s Domain
The fact that everything looks different doesn’t mean that all has changed…
Hero image

(Markku) Michael Jeltsch

1 min read • 72 words
Finnish/German biochemist researching and teaching at the University of Helsinki

(

) Michael Jeltsch

  • Moved from Germany to Finland in 1995
  • PhD  (University of Helsinki 2003 with Kari Alitalo  )
  • Discovery and characterization of the first lymphangiogenic growth factors VEGF-C and VEGF-D ( Jeltsch et al. 1997, Science  ; Achen et al. 1998, PNAS  )
  • Experience in three biotech startups with numerous patents for biopharmaceuticals
  • Biopharmaceuticals VGX-100, Lymfactin, and OPT-302/CYV-101 progressed into clinical trials, representing important milestones in their development.